-
1دورية أكاديمية
المؤلفون: M. Fevzi Ozkaynak, Andrew L. Gilman, Wendy B. London, Arlene Naranjo, Mitchell B. Diccianni, Sheena C. Tenney, Malcolm Smith, Karen S. Messer, Robert Seeger, C. Patrick Reynolds, L. Mary Smith, Barry L. Shulkin, Marguerite Parisi, John M. Maris, Julie R. Park, Paul M. Sondel, Alice L. Yu
المصدر: Frontiers in Immunology, Vol 9 (2018)
مصطلحات موضوعية: neuroblastoma, immunotherapy, anti-GD2 chimeric antibody, cytokines, safety, cytokine biomarkers, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/article/10.3389/fimmu.2018.01641/fullTest; https://doaj.org/toc/1664-3224Test
-
2دورية أكاديمية
المؤلفون: M. Fevzi Ozkaynak, Andrew L. Gilman, Wendy B. London, Arlene Naranjo, Mitchell B. Diccianni, Sheena C. Tenney, Malcolm Smith, Karen S. Messer, Robert Seeger, C. Patrick Reynolds, L. Mary Smith, Barry L. Shulkin, Marguerite Parisi, John M. Maris, Julie R. Park, Paul M. Sondel, Alice L. Yu
المصدر: Frontiers in Immunology, Vol 9 (2018)
مصطلحات موضوعية: neuroblastoma, immunotherapy, anti-GD2 chimeric antibody, cytokines, safety, cytokine biomarkers, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/article/10.3389/fimmu.2018.01355/fullTest; https://doaj.org/toc/1664-3224Test
-
3
المؤلفون: Julie M. Gastier-Foster, Barry L. Shulkin, Steven G. DuBois, Daniel von Allmen, Michael D. Hogarty, Gregory A. Yanik, M. Meaghan Granger, Wendy B. London, Denise Mills, Julie R. Park, Yael P. Mosse, Marguerite T. Parisi, S. Grupp, Brian Weiss, Shahab Asgharzadeh, Jeannine S. McCune, Joseph Panoff, Arlene Naranjo, John Han-Chang, Jason A. Jarzembowski, Sheena C. Tenney, Rochelle Bagatell
المصدر: Transplant Cell Ther
مصطلحات موضوعية: Oncology, Melphalan, medicine.medical_specialty, medicine.medical_treatment, Transplantation, Autologous, Article, Neuroblastoma, Autologous stem-cell transplantation, Internal medicine, Humans, Immunology and Allergy, Medicine, Child, Busulfan, Preparative Regimen, Transplantation, Chemotherapy, business.industry, Hematopoietic Stem Cell Transplantation, Induction chemotherapy, Induction Chemotherapy, Cell Biology, Hematology, Tolerability, Molecular Medicine, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a136309d8163e9fbf8718d1741908208Test
https://doi.org/10.1016/j.jtct.2021.03.006Test -
4
المؤلفون: Julie R. Park, Sheena C. Tenney, Alice L. Yu, Paul M. Sondel, L. Mary Smith, Wendy B. London, Karen Messer, Marguerite T. Parisi, Arlene Naranjo, Robert C. Seeger, Mitchell B. Diccianni, Andrew L. Gilman, John M. Maris, M. Fevzi Ozkaynak, Malcolm A. Smith, Barry L. Shulkin, C. Patrick Reynolds
المصدر: Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunologyمصطلحات موضوعية: 0301 basic medicine, medicine.medical_treatment, Gastroenterology, law.invention, Neuroblastoma, 0302 clinical medicine, Randomized controlled trial, law, Immunology and Allergy, Isotretinoin, 6.2 Cellular and gene therapies, Cancer, Pediatric, Clinical Trial, 3. Good health, Cytokine, Medical Microbiology, 030220 oncology & carcinogenesis, 6.1 Pharmaceuticals, Neuropathic pain, Monoclonal, immunotherapy, Patient Safety, medicine.drug, lcsh:Immunologic diseases. Allergy, safety, medicine.medical_specialty, Pediatric Research Initiative, Pediatric Cancer, Clinical Trials and Supportive Activities, Immunology, cytokine biomarkers, Vaccine Related, 03 medical and health sciences, neuroblastoma, Rare Diseases, Clinical Research, Internal medicine, medicine, business.industry, Neurosciences, Evaluation of treatments and therapeutic interventions, anti-GD2 chimeric antibody, Immunotherapy, medicine.disease, cytokines, 030104 developmental biology, Orphan Drug, Concomitant, Immunization, business, lcsh:RC581-607
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08b24faba4214d05175d3a9acbfd6704Test
-
5
المؤلفون: M. Fevzi Ozkaynak, Andrew L. Gilman, Wendy B. London, Arlene Naranjo, Mitchell B. Diccianni, Sheena C. Tenney, Malcolm Smith, Karen S. Messer, Robert Seeger, C. Patrick Reynolds, L. Mary Smith, Barry L. Shulkin, Marguerite Parisi, John M. Maris, Julie R. Park, Paul M. Sondel, Alice L. Yu
مصطلحات موضوعية: Immunology, Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies), Autoimmunity, Cellular Immunology, Humoural Immunology and Immunochemistry, Immunogenetics (incl. Genetic Immunology), Innate Immunity, Transplantation Immunology, Tumour Immunology, Immunology not elsewhere classified, Genetic Immunology, Animal Immunology, Veterinary Immunology, neuroblastoma, immunotherapy, anti-GD2 chimeric antibody, cytokines, safety, cytokine biomarkers
الإتاحة: https://doi.org/10.3389/fimmu.2018.01355.s002Test
https://figshare.com/articles/dataset/table_1_A_Comprehensive_Safety_Trial_of_Chimeric_Antibody_14_18_With_GM-CSF_IL-2_and_Isotretinoin_in_High-Risk_Neuroblastoma_Patients_Following_Myeloablative_Therapy_Children_s_Oncology_Group_Study_ANBL0931_PDF/6586289Test -
6
المؤلفون: M. Fevzi Ozkaynak, Andrew L. Gilman, Wendy B. London, Arlene Naranjo, Mitchell B. Diccianni, Sheena C. Tenney, Malcolm Smith, Karen S. Messer, Robert Seeger, C. Patrick Reynolds, L. Mary Smith, Barry L. Shulkin, Marguerite Parisi, John M. Maris, Julie R. Park, Paul M. Sondel, Alice L. Yu
مصطلحات موضوعية: Immunology, Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies), Autoimmunity, Cellular Immunology, Humoural Immunology and Immunochemistry, Immunogenetics (incl. Genetic Immunology), Innate Immunity, Transplantation Immunology, Tumour Immunology, Immunology not elsewhere classified, Genetic Immunology, Animal Immunology, Veterinary Immunology, neuroblastoma, immunotherapy, anti-GD2 chimeric antibody, cytokines, safety, cytokine biomarkers
الإتاحة: https://doi.org/10.3389/fimmu.2018.01355.s001Test
https://figshare.com/articles/dataset/data_sheet_1_A_Comprehensive_Safety_Trial_of_Chimeric_Antibody_14_18_With_GM-CSF_IL-2_and_Isotretinoin_in_High-Risk_Neuroblastoma_Patients_Following_Myeloablative_Therapy_Children_s_Oncology_Group_Study_ANBL0931_doc/6586286Test